Archives - September 11, 2026 - NutraIngredients.com

NI+New bill seeks to fix drug preclusion provision to boost dietary supplement innovation

12-Sep-2026

By Stephen Daniells

Congresswoman Diana Harshbarger (R-TN) introduced the Dietary Supplement Innovation Act with the aim of modernizing the Food and Drug Administration’s (FDA) drug preclusion provision, a move that has been welcomed by dietary supplement trade associations.

AI Shelf Space seeks greater visibility for supplement companies

11-Sep-2026

By Claudia Adrien

Independent measurement service AI Shelf Space offers a free index ranking of supplement brands based on performance on AI-powered answer engines like ChatGPT, Google Gemini and Claude.

Patent maps new route to NAD+ production via engineered yeast

11-Sep-2026

By Cassandra Stern

A newly published patent details a fermentation-based approach to producing NAD+, using genetically engineered yeast to generate the coenzyme for potential use in supplements, functional foods and beverages.

NI+Gnosis secures EFSA approval for novel glutathione form

11-Sep-2026

By Lauren Nicolle

EFSA has published a positive safety opinion on S-acetyl glutathione (SAG), a chemically modified version of glutathione designed to enhance bioavailability.

Lehvoss combines Zooca calanus oil with Golden Omega to create ZOΩ3GO Softgels

11-Sep-2026

By Nikki Hancocks

Lehvoss UK Ltd has launched ZOΩ3GO Softgels, a new trademark and finished product for the European and US market combining sustainable and science-based marine lipids to meet consumers’ ‘maturing’ expectations.

Regulatory review: Ingredients safety re-evaluation, NMN product naming and more

11-Sep-2026

By Tingmin Koe

South Korea’s Ministry of Food and Drug Safety’s (MFDS) re-evaluation of functional ingredients such as bilberry extract and Australia’s Therapeutic Goods Administration’s (TGA) guidance on NMN product naming are some of the latest updates in this...